CSIMarket
 


Eli Lilly And Company  (LLY)
Other Ticker:  
 
 

LLY's EPS Net Growth by Quarter and Year

Eli Lilly And's EPS Net results by quarter and year




LLY EPS Net (in $) FY 2021 FY 2020 FY 2019 FY 2018
IV Quarter December - 2.31 1.64 0.31
III Quarter September - 1.33 1.37 1.12
II Quarter June - 1.55 1.44 -0.25
I Quarter March 1.49 1.60 4.31 1.16
FY   1.49 6.79 8.76 2.34



LLY EPS Net first quarter 2021 Y/Y Growth Comment
Eli Lilly And Company reported decrease in EPS Net in the first quarter by -6.88% to $ 1.49 , from the same quarter in 2020.
The decrease in the first quarter Eli Lilly And Company's EPS Net compares unfavorably to the Company's average EPS Net growth of 4.52%.

Looking into first quarter results within Major Pharmaceutical Preparations industry 7 other companies have achieved higher EPS Net growth. While Eli Lilly And Company' s EPS Net decline of -6.88% ranks overall at the positon no. 415 in the first quarter.




LLY EPS Net ( Y/Y Growth %) 2021
2020 2019 2018
IV Quarter December - 40.85 % 429.03 % -
III Quarter September - -2.92 % 22.32 % 111.32 %
II Quarter June - 7.64 % - -
I Quarter March -6.88 % -62.88 % 271.55 % -
FY   - -22.49 % 274.36 % -

Financial Statements
Eli Lilly And's first quarter 2021 EPS Net $ 1.49 LLY's Income Statement
Eli Lilly And's first quarter 2020 EPS Net $ 1.60 Quarterly LLY's Income Statement
New: More LLY's historic EPS Net Growth >>


LLY EPS Net (Quarter on Quarter Growth %)

2021
2020 2019 2018
IV Quarter December - 73.68 % 19.71 % -72.32 %
III Quarter September - -14.19 % -4.86 % -
II Quarter June - -3.13 % -66.59 % -
I Quarter March -35.5 % -2.44 % 1290.32 % -
FY (Year on Year)   - -22.49 % 274.36 % -




EPS Net first quarter 2021 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #8
Healthcare Sector #33
Overall #415

EPS Net Y/Y Growth Statistics
High Average Low
134.69 % 4.52 % -36.78 %
(Mar 31 2019)   (Sep. 30. 2008)
EPS Net first quarter 2021 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #8
Healthcare Sector #33
Overall #415
EPS Net Y/Y Growth Statistics
High Average Low
134.69 % 4.52 % -36.78 %
(Mar 31 2019)   (Sep. 30. 2008)

EPS Net by Quarter for the Fiscal Years 2018, 2019, 2020, 2021

Eli Lilly And's Q/Q EPS Net Growth


EPS Net Q/Q Growth Statistics
High Average Low
1296.14 % 25.29 % -100 %
(Mar 31 2019)  


LLY's I. Quarter Q/Q EPS Net Comment
In the I. Quarter 2021 Eli Lilly And Company reported fall in EPS Net from the forth quarter by -35.5% to $ 1.49 , from $ 2.31 released a quarter before.

As we look into recent downturn in the I. Quarter 2021, we suppose to assume, that commonly I. Quarter 2021 results occur sluggish then in the quarter before

Within Major Pharmaceutical Preparations industry 7 other companies have achieved higher EPS Net quarter on quarter growth. While Eli Lilly And's EPS Net growth quarter on quarter, overall rank is 411.


EPS Net Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #8
Healthcare Sector #31
Overall #411
EPS Net Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #8
Healthcare Sector #31
Overall #411
EPS Net Q/Q Growth Statistics
High Average Low
1296.14 % 25.29 % -100 %
(Mar 31 2019)  


LLY's I. Quarter Q/Q EPS Net Comment
In the I. Quarter 2021 Eli Lilly And Company realized fall in EPS Net from the forth quarter by -35.5% to $ 1.49 , from $ 2.31 released in the previous quarter.

If you evaluate current downturn in the I. Quarter 2021, you must presume, that frequently I. Quarter performance emerge softer relative to the quarter before

Within Major Pharmaceutical Preparations industry 7 other companies have achieved higher EPS Net quarter on quarter growth. While Eli Lilly And's EPS Net growth quarter on quarter, overall rank is 411.


Eli Lilly And's 12 Months EPS Net Growth Year on Year


EPS Net TTM Growth

12 Months Ending
(Mar 31 2021)
12 Months Ending
(Dec 31 2020)
12 Months Ending
(Sep 30 2020)
12 Months Ending
(Jun 30 2020)
12 Months Ending
(Mar 31 2020)
Cumulative EPS Net 12 Months Ending $ 6.68 $ 6.79 $ 6.12 $ 6.16 $ 6.05
Y / Y EPS Net Growth (TTM) 10.43 % -22.48 % -17.62 % -14.19 % 10.23 %
Year on Year EPS Net Growth Overall Ranking # 257 # 341 # 343 # 1013 # 259
Seqeuential EPS Net Change (TTM) -1.62 % 10.96 % -0.65 % 1.82 % -30.94 %
Seq. EPS Net Growth (TTM) Overall Ranking # 415 # 398 # 664 # 234 # 679




Cumulative EPS Net growth Comment
Although Eli Lilly And's Annual EPS Net growth year on year were below company's average 45.34% , EPS Net announced in the Mar 31 2021 period, show improvement in EPS Net trend, to cumulative trailing twelve month growth of 10.43% year on year, from -22.48% in Dec 31 2020.

Among companies within the Healthcare sector 20 other companies have achieved higher trailing twelve month EPS Net growth. While Total ranking has impoved so far to 257, from total ranking in previous quarter at 341.

EPS Net TTM Q/Q Growth Statistics
High Average Low
134.69 %
4.52 %
-36.78 %
 

EPS Net TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 8
Healthcare Sector # 21
Overall # 257

EPS Net TTM Y/Y Growth Statistics
High Average Low
1580.68 %
45.34 %
-79.01 %
 


EPS Net TTM Q/Q Growth Company Ranking
Within: No.
Industry # 8
Sector # 33
S&P 500 # 415
Cumulative EPS Net growth Comment
Although Eli Lilly And's Annual EPS Net growth year on year were below company's average 45.34% , EPS Net announced in the Mar 31 2021 period, show improvement in EPS Net trend, to cumulative trailing twelve month growth of 10.43% year on year, from -22.48% in Dec 31 2020.

Among companies within the Healthcare sector 20 other companies have achieved higher trailing twelve month EPS Net growth. While Total ranking has impoved so far to 257, from total ranking in previous quarter at 341.

EPS Net TTM Q/Q Growth Statistics
High Average Low
134.69 %
4.52 %
-36.78 %
 


EPS Net TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 8
Healthcare Sector # 21
Overall # 257

EPS Net TTM Y/Y Growth Statistics
High Average Low
1580.68 %
45.34 %
-79.01 %
 


EPS Net TTM Q/Q Growth Company Ranking
Within: No.
Industry # 8
Sector # 33
S&P 500 # 415




Other EPS Net Growth
Major Pharmaceutical Preparations Industry EPS Net Growth Trends and Statistics
Healthcare Sector EPS Net Growth Statistics
EPS Net Growth Trends for overall market
LLY's EPS Net Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking EPS Net Growth
Lowest Ranking EPS Net Growth
EPS Net Growth for LLY's Competitors
EPS Net Growth for Eli Lilly And's Suppliers
EPS Net Growth for LLY's Customers

You may also want to know
LLY's Annual Growth Rates LLY's Profitability Ratios LLY's Asset Turnover Ratio LLY's Dividend Growth
LLY's Roe LLY's Valuation Ratios LLY's Financial Strength Ratios LLY's Dividend Payout Ratio
LLY's Roa LLY's Inventory Turnover Ratio LLY's Growth Rates LLY's Dividend Comparisons



Companies with similar EPS Net fall for the quarter ending Mar 31 2021 within Healthcare SectorY/Y Change %EPS Net for the quarter ending Mar 31 2021
Merck and Co Inc -0.79%$ -0.794 
Abbvie Inc -1.49%$ -1.485 
Prestige Consumer Healthcare Inc -3.22%$ -3.220 
Eli Lilly And Company-6.88%$ -6.875 
Amgen Inc -7.82%$ -7.818 
Phibro Animal Health Corp-9.09%$ -9.091 
Baxter International Inc -9.38%$ -9.375 
Atrion Corporation-11.90%$ -11.900 
Neurocrine Biosciences Inc -15.38%$ -15.385 
Msa Safety Inc-17.12%$ -17.117 
Iradimed Corp-21.43%$ -21.429 
National Research Corporation-21.74%$ -21.739 
Corcept Therapeutics Inc-28.00%$ -28.000 
Catalyst Pharmaceuticals Inc -30.00%$ -30.000 
Alpha Pro Tech Ltd-30.77%$ -30.769 
Teleflex Incorporated-43.17%$ -43.165 
Anika Therapeutics Inc -50.00%$ -50.000 
Vyne Therapeutics Inc -55.79%$ -55.789 
Edwards Lifesciences Corporation-63.27%$ -63.265 
Viemed Healthcare Inc -63.64%$ -63.636 
Biogen Inc -66.71%$ -66.708 
Endo International Plc-69.64%$ -69.643 
The Pennant Group Inc -70.00%$ -70.000 
Acadia Healthcare Company Inc -71.05%$ -71.053 
Supernus Pharmaceuticals inc -72.50%$ -72.500 
Biomarin Pharmaceutical Inc-79.55%$ -79.545 
United Therapeutics Corporation-80.45%$ -80.449 
Align Technology inc -86.93%$ -86.934 
Assertio Holdings inc -94.83%$ -94.828 
Amneal Pharmaceuticals Inc -94.87%$ -94.872 


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

RUTH's Profile

Stock Price

RUTH's Financials

Business Description

Fundamentals

Charts & Quotes

RUTH's News

Suppliers

RUTH's Competitors

Customers & Markets

Economic Indicators

RUTH's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2021 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071